GW Pharmaceuticals PLC GWPH:NASDAQ

Last Price$103.07Cboe Real-Time Last Sale as of 2:29PM ET 11/18/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-5.34(4.93%)
Bid (Size)$102.63 (100)
Ask (Size)$103.59 (48)
Day Low / High$102.05 - 108.75
Volume676.9 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 11/18/2019

 

GW Pharmaceuticals PLC ( NASDAQ )

Price: $103.07
Change: -5.34 (4.93%)
Volume: 676.9 K
2:29PM ET 11/18/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

European ADRs Move Higher in Monday Trading
11:07AM ET 11/18/2019 MT Newswires

American depositary receipts of European stocks were trading 0.044% higher at 1,051.59 on the BNY Mellon Europe Select ADR Index on Monday. In continental...

Continued Level of Significant Insider Selling at GW Pharmaceuticals (GWPH)
10:21PM ET 11/14/2019 MT Newswires

One insider -- Dr Geoffrey W Guy, Director and Officer -- today, sold 420,000 shares of GW Pharmaceuticals having a market value of approximately...

ADR Top % Movers in Pre-Market Trading
6:43AM ET 11/14/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers SAN +2.3% CUK +0.9% RIO +0.6% GWPH +0.4% BP +0.3% Losers NOK -2.3% GSK -1.5% VOD -1.2% HSBC -0.4% STM -0.2%...

Insider Trends: Insider Adds to Selling Trend at GW Pharmaceuticals
5:03PM ET 11/13/2019 MT Newswires

Dr Geoffrey W Guy, Director and Executive Chairman, executed a sale of 420,000 shares in GW Pharmaceuticals (GWPH) on Nov 11, 2019, for $3,918,600. Dr...

View all Commentary and Analysis

Charlotte's Web: 'We've Seen More Crowding'
5:59PM ET 11/14/2019 Seeking Alpha

GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day
10:38AM ET 11/14/2019 Zacks

GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day

GW Pharmaceuticals Tumbles On Earnings Beat, But Its Growth Story Is Only Beginning
4:50PM ET 11/13/2019 Seeking Alpha

Wall Street Breakfast: Alibaba Sets New Singles' Day Record
6:40AM ET 11/11/2019 Seeking Alpha

Company Profile

Business DescriptionGW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. View company web site for more details
AddressSovereign House
Cambridge, Cambridgeshire CB24 9BZ
Phone+44.1223.266800
Number of Employees801
Recent SEC Filing11/13/20194
Chief Executive Officer & Executive DirectorJustin D. Gover
Chief Operating OfficerChristopher John Tovey
CFO & Principal Accounting OfficerScott M. Giacobello
Chief Medical OfficerVolker Knappertz

Company Highlights

Price Open$108.70
Previous Close$108.41
52 Week Range$90.14 - 196.00
Market Capitalization$3.2 B
Shares Outstanding30.9 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement02/25/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$4.34
Beta vs. S&P 500N/A
Revenue$15.5 M
Net Profit Margin-100.16%
Return on Equity-19.42%

Analyst Ratings as of 10/29/2019

Buy
15
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset